Effectiveness of vitamin B and E in reducing pai

Not Applicable

• Conditions: Osteoarthritis of the knee.; Arthrosis, unspecified

• Registration Number: IRCT201408306480N7
• Lead Sponsor: Shahrekord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Inclusion criteria included : having 30 to 60 years of age, a diagnosis of primary osteoarthritis of the knee by an orthopedic doctor( based on history, clinical signs, physical examination, and radiographic diagnosis of the disease and diagnostic criteria related to this disease) . Exclusion criteria included : secondary osteoarthritis, infection or inflammatory disease of the knee joint, crystal-induced arthritis, tumors, intra-articular, knee ligament instability, previous fracture, intra-articular, knee surgery (arthroscopic or other in the past 12 months, an intra-articular injection, visual analog score less than 3 on the knee therapy in the treatment , severe concurrent disorders such as metabolic disorders and a history of certain diseases, including stroke in the past, uncontrolled hypertension, gastritis, infectious diseases, kidney failure, stomach ulcers, allergies to medications (vitamin B complex, vitamin E, vitamin B and E and the other contradictions receptor of vitamin E and B

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Morning stiffness. Timepoint: Intervention, two weeks and three weeks later. Method of measurement: Western Ontario MacMaster questionnaire.;Pain. Timepoint: Intervention, two weeks and three weeks later. Method of measurement: Visual analog scale (VAS).;Physical function. Timepoint: Intervention, two weeks and three weeks later. Method of measurement: Western Ontario MacMaster questionnaire.

Secondary Outcome Measures

Name	Time	Method
Consent to treatment. Timepoint: Three weeks after treatment. Method of measurement: questionnaire.